F.H. O’Neill

623 total citations
19 papers, 485 citations indexed

About

F.H. O’Neill is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, F.H. O’Neill has authored 19 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 6 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Cancer Research. Recurrent topics in F.H. O’Neill's work include Lipoproteins and Cardiovascular Health (7 papers), Cancer, Lipids, and Metabolism (5 papers) and Cholesterol and Lipid Metabolism (5 papers). F.H. O’Neill is often cited by papers focused on Lipoproteins and Cardiovascular Health (7 papers), Cancer, Lipids, and Metabolism (5 papers) and Cholesterol and Lipid Metabolism (5 papers). F.H. O’Neill collaborates with scholars based in United Kingdom, South Africa and Australia. F.H. O’Neill's co-authors include Gilbert R. Thompson, Saheed Sabiu, Anofi Omotayo Tom Ashafa, T. A. B. Sanders, Dick C. Chan, P. Hugh R. Barrett, Gerald F. Watts, Graham W. Taylor, A. David Marais and Dirk Blom and has published in prestigious journals such as Arteriosclerosis Thrombosis and Vascular Biology, The American Journal of Cardiology and Clinical Chemistry.

In The Last Decade

F.H. O’Neill

19 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F.H. O’Neill United Kingdom 12 241 153 136 72 67 19 485
Giuliana Mombelli Italy 11 212 0.9× 101 0.7× 129 0.9× 36 0.5× 40 0.6× 31 514
C A Marzetta United States 9 225 0.9× 208 1.4× 106 0.8× 65 0.9× 22 0.3× 11 446
Brian Jackson United Kingdom 13 185 0.8× 91 0.6× 284 2.1× 96 1.3× 50 0.7× 17 619
Anthony H.M. Terpstra Netherlands 9 222 0.9× 148 1.0× 169 1.2× 57 0.8× 23 0.3× 11 655
Lynn Crosbie United Kingdom 12 90 0.4× 54 0.4× 65 0.5× 25 0.3× 59 0.9× 15 414
Yanhong Si China 12 67 0.3× 45 0.3× 168 1.2× 41 0.6× 64 1.0× 20 371
Lingzhi Cai China 11 120 0.5× 119 0.8× 239 1.8× 33 0.5× 30 0.4× 18 797
Naruemon Klaikeaw Thailand 14 122 0.5× 69 0.5× 140 1.0× 18 0.3× 51 0.8× 29 472
Hideki Mori Japan 15 95 0.4× 41 0.3× 275 2.0× 97 1.3× 89 1.3× 40 687
Yunsheng Xu China 15 53 0.2× 67 0.4× 372 2.7× 165 2.3× 48 0.7× 53 773

Countries citing papers authored by F.H. O’Neill

Since Specialization
Citations

This map shows the geographic impact of F.H. O’Neill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.H. O’Neill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.H. O’Neill more than expected).

Fields of papers citing papers by F.H. O’Neill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.H. O’Neill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.H. O’Neill. The network helps show where F.H. O’Neill may publish in the future.

Co-authorship network of co-authors of F.H. O’Neill

This figure shows the co-authorship network connecting the top 25 collaborators of F.H. O’Neill. A scholar is included among the top collaborators of F.H. O’Neill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F.H. O’Neill. F.H. O’Neill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Sabiu, Saheed, et al.. (2021). Reactive oxygen species as potential antiviral targets. Reviews in Medical Virology. 32(1). e2240–e2240. 39 indexed citations
2.
Osthoff, Gernot, et al.. (2021). Milk composition of white rhinoceros over lactation and comparison with other Perissodactyla. Zoo Biology. 40(5). 417–428. 5 indexed citations
3.
Sabiu, Saheed, F.H. O’Neill, & Anofi Omotayo Tom Ashafa. (2017). Toxicopathological evaluation of a 28-day repeated dose administration ofZea maysL. (Poaceae),Stigma maydisaqueous extract on key metabolic markers of Wistar rats. Transactions of the Royal Society of South Africa. 72(3). 225–233. 7 indexed citations
4.
Sabiu, Saheed, F.H. O’Neill, & Anofi Omotayo Tom Ashafa. (2016). THE PURVIEW OF PHYTOTHERAPY IN THE MANAGEMENT OF KIDNEY DISORDERS: A SYSTEMATIC REVIEW ON NIGERIA AND SOUTH AFRICA. African Journal of Traditional Complementary and Alternative Medicines. 13(5). 38–47. 14 indexed citations
5.
Sabiu, Saheed, F.H. O’Neill, & Anofi Omotayo Tom Ashafa. (2016). Membrane Stabilization and Detoxification of Acetaminophen‐Mediated Oxidative Onslaughts in the Kidneys of Wistar Rats by Standardized Fraction of Zea mays L. (Poaceae), Stigma maydis. Evidence-based Complementary and Alternative Medicine. 2016(1). 2046298–2046298. 3 indexed citations
6.
Sabiu, Saheed, F.H. O’Neill, & Anofi Omotayo Tom Ashafa. (2016). Kinetics of α -amylase and α -glucosidase inhibitory potential of Zea mays Linnaeus (Poaceae), Stigma maydis aqueous extract: An in vitro assessment. Journal of Ethnopharmacology. 183. 1–8. 77 indexed citations
7.
O’Neill, F.H., T. A. B. Sanders, & Gilbert R. Thompson. (2005). Comparison of Efficacy of Plant Stanol Ester and Sterol Ester: Short-Term and Longer-Term Studies. The American Journal of Cardiology. 96(1). 29–36. 59 indexed citations
8.
Blom, Dirk, F.H. O’Neill, & A. David Marais. (2005). Screening for Dysbetalipoproteinemia by Plasma Cholesterol and Apolipoprotein B Concentrations. Clinical Chemistry. 51(5). 904–907. 40 indexed citations
9.
O’Neill, F.H., Audrey E. Brynes, Nigel B. Rendell, et al.. (2004). Comparison of the effects of dietary plant sterol and stanol esters on lipid metabolism. Nutrition Metabolism and Cardiovascular Diseases. 14(3). 133–142. 42 indexed citations
10.
Chan, Dick C., Gerald F. Watts, P. Hugh R. Barrett, F.H. O’Neill, & Gilbert R. Thompson. (2003). Plasma Markers of Cholesterol Homeostasis and Apolipoprotein B‐100 Kinetics in the Metabolic Syndrome. Obesity Research. 11(4). 591–596. 30 indexed citations
11.
Naoumova, R.P., D. Patel, F.H. O’Neill, G. R. Thompson, & Brian L. Knight. (2003). Treatment with atorvastatin alters interleukin‐12 and ‐10 gene expression. European Journal of Clinical Investigation. 33(1). 88–91. 7 indexed citations
12.
Chan, Dick C., Gerald F. Watts, P. Hugh R. Barrett, et al.. (2003). Relationships between cholesterol homoeostasis and triacylglycerol-rich lipoprotein remnant metabolism in the metabolic syndrome. Clinical Science. 104(4). 383–383. 40 indexed citations
13.
Naoumova, R.P., D. Patel, F.H. O’Neill, G. R. Thompson, & Brian L. Knight. (2003). Treatment with atorvastatin alters the ratio of interleukin‐12/interleukin‐10 gene expression. European Journal of Clinical Investigation. 33(4). 359–359. 5 indexed citations
14.
Chan, Dick C., Gerald F. Watts, P. Hugh R. Barrett, et al.. (2003). Relationships between cholesterol homoeostasis and triacylglycerol-rich lipoprotein remnant metabolism in the metabolic syndrome. Clinical Science. 104(4). 383–388. 19 indexed citations
15.
O’Neill, F.H., Dilip D. Patel, Brian L. Knight, et al.. (2001). Determinants of Variable Response to Statin Treatment in Patients With Refractory Familial Hypercholesterolemia. Arteriosclerosis Thrombosis and Vascular Biology. 21(5). 832–837. 52 indexed citations
16.
O’Neill, F.H., et al.. (2001). Enhancement of cholesterol-lowering effect of atorvastatin by stanol ester cereal bars. Atherosclerosis Supplements. 2(2). 110–110. 4 indexed citations
17.
19.
O’Neill, F.H., L. P. Christov, P.J. Botes, & Bernard A. Prior. (1996). Rapid and simple assay for feruloyl and p-coumaroyl esterases. World Journal of Microbiology and Biotechnology. 12(3). 239–242. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026